Terms: = Thyroid cancer AND MYC, c-Myc, 4609, ENSG00000136997
291 results:
1. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
3. Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma.
Zhou L; He L; Liu CH; Qiu H; Zheng L; Sample KM; Wu Q; Li J; Xie K; Ampuero J; Li Z; Lv D; Liu M; Romero-Gómez M; Hu Y; Tang H
J Exp Clin Cancer Res; 2023 Nov; 42(1):311. PubMed ID: 37993901
[TBL] [Abstract] [Full Text] [Related]
4. Upregulated TC1 and downregulated Chibby were correlated with the aberrant β-catenin expression in laryngeal squamous cell carcinoma.
Ren G; Ma B; Wang J; Xu J; Zhang X; Yin C
Medicine (Baltimore); 2023 Nov; 102(46):e36066. PubMed ID: 37986347
[TBL] [Abstract] [Full Text] [Related]
5. The m
Li P; Wang W; Zhou R; Ding Y; Li X
Clin Transl Med; 2023 Nov; 13(11):e1466. PubMed ID: 37983928
[TBL] [Abstract] [Full Text] [Related]
6. Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer.
Zhang Z; Zhou J; Guo R; Zhou Q; Wang L; Xiang X; Ge S; Cui Z
Medicine (Baltimore); 2023 Nov; 102(45):e34871. PubMed ID: 37960775
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract] [Full Text] [Related]
8. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
9. Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-myc-mediated glycolysis.
Han J; Xie C; Liu B; Wang Y; Pang R; Bi W; Sheng R; He G; Kong L; Yu J; Ding Z; Chen L; Jia J; Zhang J; Nie C
Cancer Sci; 2023 Dec; 114(12):4535-4547. PubMed ID: 37750019
[TBL] [Abstract] [Full Text] [Related]
10. Methylation-Mediated Silencing of ATF3 Promotes thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
11. Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-myc complex-mediated glutamine starvation.
Zeng Y; Jiang H; Zhang X; Xu J; Wu X; Xu Q; Cai W; Ying H; Zhou R; Ding Y; Ying K; Song X; Chen Z; Zeng L; Zhao L; Yu F
Free Radic Biol Med; 2023 Nov; 208():571-586. PubMed ID: 37696420
[TBL] [Abstract] [Full Text] [Related]
12. myc-Associated Zinc Finger Protein Promotes Metastasis of Papillary thyroid cancer.
Zheng C; Wu H; Zhang S; Tian R; Long H; Zhang H; Guo X; Li D; Tan S; Zhu X
Front Biosci (Landmark Ed); 2023 Aug; 28(8):162. PubMed ID: 37664917
[TBL] [Abstract] [Full Text] [Related]
13. Exosome-Mediated lncRNA LINC01140 Attenuates Breast cancer Progression by Regulating the Wnt/β-Catenin Pathway.
Guo Z; Li Y; Li W; Li H; Wu Z
Crit Rev Eukaryot Gene Expr; 2023; 33(7):31-42. PubMed ID: 37602451
[TBL] [Abstract] [Full Text] [Related]
14. Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health.
Durrani IA; Bhatti A; John P
PLoS One; 2023; 18(8):e0289839. PubMed ID: 37556419
[TBL] [Abstract] [Full Text] [Related]
15. STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells.
Li X; Liu Y; Liu J; Qiang W; Ma J; Xie J; Chen P; Wang Y; Hou P; Ji M
Cell Death Dis; 2023 Jul; 14(7):454. PubMed ID: 37479689
[TBL] [Abstract] [Full Text] [Related]
16. Identification of BRAF, CCND1, and myc mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
17. Screening and Bioinformatics Analysis of MicroRNA Biomarkers in Triple-Negative Breast cancer.
Fan J; Dong C; Ma B
Crit Rev Eukaryot Gene Expr; 2023; 33(5):29-37. PubMed ID: 37199312
[TBL] [Abstract] [Full Text] [Related]
18. TCF12 regulates exosome release from epirubicin-treated CAFs to promote ER+ breast cancer cell chemoresistance.
Qiu Y; Wang X; Sun Y; Du YE; Yin G; Luo H; Wen S; Lang L; Liu M; Tang X
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166727. PubMed ID: 37137433
[TBL] [Abstract] [Full Text] [Related]
19. TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway.
Jiang Q; Guan Y; Zheng J; Lu H
Immun Inflamm Dis; 2023 Mar; 11(3):e796. PubMed ID: 36988258
[TBL] [Abstract] [Full Text] [Related]
20. FOXA2 suppresses PKM2 transcription and affects the Wnt/β-catenin activity to block aerobic glycolysis in thyroid carcinoma.
He Y; Chen W; Yu L; Liu Y; Cheng Y; Li X; Yu G
Clin Exp Pharmacol Physiol; 2023 Jul; 50(7):561-572. PubMed ID: 36946190
[TBL] [Abstract] [Full Text] [Related]
[Next]
